B3GAT1 and neoplasm: Knockdown of Sgl or GlcAT-P significantly rescued tumour-induced lethality in the presence of trametinib; neither knockdown impacted byn > RAP survival in the absence of trametinib or in control animals (Fig. 1d–f).